Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients
Multicenter Study
[키워드] Against
age
Analysis
Antibody Response
BNT162b2
chronic
clinical
clinical immunology
cohort study
Control
controls
COVID-19
COVID-19 mRNA vaccine
Cutoff
dialysis
dose
evaluated
first vaccination
high risk
humoral
humoral immune response
IgG level
immune
immune response
Immunity
Impaired
kidney
Kidney failure
kidney transplant recipient
Kidney transplantation
Modification
MOST
mRNA-1273
neutralization capacity
neutralizing antibody
Neutralizing antibody titer
Patient
Prophylaxis
recipient
renal
renal insufficiency
response
SARS-CoV-2
SARS-CoV-2 specific antibody
SARS-CoV-2 vaccination
SARS-CoV-2-specific antibody
SARS-CoV-2-specific IgG
second vaccination
Severe COVID-19 Infection
significantly
significantly lower
Transplant
transplantation
undetectable
vaccination
Vaccination strategy
Vaccine
Virology
were measured
[DOI] 10.34067/KID.0003512021 PMC 바로가기 [Article Type] Multicenter Study
[DOI] 10.34067/KID.0003512021 PMC 바로가기 [Article Type] Multicenter Study